What is INGN's market cap?

$191.61M, based on the Nov 4 close of $7.22.

Does Inogen pay a dividend?

No regular cash dividend has been paid in the last year.

How much of INGN is sold short?

1.5M shares, 6.6% of float, as of Oct 15, 2026.

What sector is INGN in?

Healthcare, in the Orthopedic & Surgical Supplies industry.

NASDAQ · INGNHealthcareOrthopedic & Surgical Supplies

Inogen Inc (INGN)

$7.22+2.85%

Close Nov 4, 2026 · split-adjusted

Oct 30, 2026$6.86▼ 16.44% in range

Nov 3, 2025Low $5.09 · High $8.21Oct 30, 2026

What changed · written from our data

As of Nov 4, 2026

Inogen closed at $7.22 on Nov 4, up 2.85%, 12.1% below its 52-week closing high. Volume of 285.5K shares was 1.09× its 20-day average (close to normal).

Split-adjusted performance: +25.1% over one month, +1.5% over six months, -12.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $95.08M, up 3.0% from a year earlier, with a net margin of -4.0%.

Short interest was 1.5M shares at the Oct 15 settlement, up 3.9% from the prior report (6.6% of float, 4.1 days to cover).

Market cap$191.6M26.5M shares

Revenue · quarter$95.1M+3.0% YoY

Diluted EPS$-0.14—

P/E · TTM—P/S 0.5×

Net margin-4.0%Gross 45.5%

Dividend yieldNone

52-week range5.09 – 8.21−12.1% from high

Volume285.5K1.09× 20-day avg

Volatility · 60d41.5%Annualised

Short % of float6.6%4.1 days to cover

Net cash$105.5MCash $105.5M

Next earnings—Not scheduled

Split-adjusted performance

1W −0.4%1M +25.1%3M +11.2%6M +1.5%YTD +7.4%1Y −12.1%3Y +63.3%5Y −81.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum50

Revenue growth16

Net margin47

Value (low P/E)—

Size48

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →

Shares short1.5M+3.9% vs prior

Days to cover4.1Settled Oct 15

% of float6.6%

Short vol. 10d42.8%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
INGNInogen	$7.22	+2.85%	+1.5%	+3.0%	−4.0%	—	$191.6M
SMTISanara MedTech	$32.33	+0.50%	+68.8%	+9.0%	−1.6%	—	$297.0M	Compare
LAKELakeland Industries	$8.93	−0.11%	−7.3%	−4.5%	−9.8%	—	$88.7M	Compare
NTRBNutriband	$6.08	−3.34%	+53.1%	−29.7%	−201.3%	—	$73.9M	Compare
CNXUConexeu Sciences	$2.22	−6.72%	—	—	—	—	$68.4M	Compare
SPAISafe Pro Group	$3.05	−3.79%	−31.8%	+1336.2%	−237.9%	—	$62.1M	Compare
AVRAnteris Technologies Global	$6.12	+9.29%	−4.2%	+63.3%	−2883.4%	—	$596.4M	Compare
APTAlpha Pro Tech	$5.74	+3.24%	+22.1%	+12.0%	9.8%	13.9	$58.6M	Compare
COCHEnvoy Medical	$7.12	+7.55%	+5.4%	−34.6%	−14258.8%	—	$55.1M	Compare

News about Inogen

All news →

No recent articles focused on Inogen.

Quick answers

What does Inogen do?: Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment.
What is INGN's market cap?: $191.61M, based on the Nov 4 close of $7.22.
Does Inogen pay a dividend?: No regular cash dividend has been paid in the last year.
How much of INGN is sold short?: 1.5M shares, 6.6% of float, as of Oct 15, 2026.
What sector is INGN in?: Healthcare, in the Orthopedic & Surgical Supplies industry.

About Inogen

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

HQ: Beverly, MA753 employeesListed Feb 14, 2014inogen.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology